Abstract
Mutations in the von Hippel–Lindau (VHL) gene are involved in the VHL family cancer syndrome and sporadic renal cell carcinoma. Previous studies indicated that VHL-induced growth arrest required high cell density and growth on extracellular matrix. In the present study, VHL protein (pVHL) levels were observed to be dramatically increased in cells grown to high cell density compared to cells grown at low cell density. Reverse transcription–polymerase chain reaction and Northern blot analysis indicated that VHL mRNA levels were equivalent in sparse and dense cells. The pVHL was rapidly degraded when cell–cell contact was disturbed by trypsinization or EDTA release. Treatment of cells with a proteasome inhibitor blocked the degradation of pVHL. Using a set of VHL deletions fused to GFP, a cell density-dependent region (CDDR) was identified and localized to the c-terminus of pVHL. In addition, other members of the VBC protein complex also showed a cell density-dependent regulation similar to pVHL. Cell density regulation of VHL did not require elongin binding and density-dependent regulation of other VBC components was not dependent on pVHL. In addition, hypoxia inducible factor-2α protein levels were elevated in sparse cells with low levels of pVHL and reduced or absent in confluent cells containing abundant VHL. These results indicate that pVHL levels and thus function are tightly regulated by cell–cell signaling. In addition, care must be taken when interpreting studies of VHL function and subcellular localization of cells grown at subconfluent conditions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amsler K . (1994). J Cell Physiol, 159, 331–339.
Baba M, Hirai S, Kawakami S, Kishida T, Sakai N, Kaneko S, Yao M, Shuin T, Kubota Y, Hosaka M and Ohno S . (2001). Oncogene, 20, 2727–2736.
Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman M and Zbar B . (1995). Hum. Mutat., 5, 66–75.
Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ and Maxwell PH . (2000). J. Biol. Chem., 275, 25733–25741.
Davidowitz EJ, Schoenfeld AR and Burk RD . (2001). Mol. Cell. Biol., 21, 865–874.
Feldman DE, Thulasiraman V, Ferreyra RG and Frydman J . (1999). Mol. Cell, 4, 1051–1061.
Folkman J and Moscona A . (1978). Nature, 273, 345–349.
Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CH and Maher ER . (1994). Hum. Mol. Genet., 3, 2169–2173.
Fuqua C, Winans SC and Greenberg EP . (1996). Annu. Rev. Microbiol., 50, 727–751.
Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B and Linehan WM . (1994). Nat. Genet., 7, 85–90.
Gumbiner BM . (1996). Cell, 84, 345–357.
Hornyak TJ, Hayes DJ and Ziff EB . (2000). J. Invest. Dermatol., 115, 106–112.
Iliopoulos O, Kibel A, Gray S and Kaelin WG . (1995). Nat. Med., 1, 822–826.
Iliopoulos O, Levy AP, Jiang C, Kaelin WG and Goldberg MA . (1996). Proc. Natl. Acad. Sci. USA, 93, 10595–10599.
Iliopoulos O, Ohh M and Kaelin Jr WG . (1998). Proc. Natl. Acad. Sci. USA, 95, 11661–11666.
Kamura T, Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS, Kaelin Jr WG, Elledge SJ, Conaway RC, Harper JW and Conaway JW . (1999). Science, 284, 657–661.
Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC and Conaway JW . (2000). Proc. Natl. Acad. Sci. USA, 97, 10430–10435.
Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin and Yao M . (1994). Can. Res., 54, 4845–4847.
Kibel A, Iliopoulos O, DeCaprio JA and Kaelin WG . (1995). Science, 269, 1444–1446.
Kojima N, Kinoshita T, Kamiya A, Nakamura K, Nakashima K, Taga T and Miyajima A . (2000). Biochem. Biophys. Res. Commun., 277, 152–158.
Krieg M, Haas R, Brauch H, Acker T, Flamme I and Plate KH . (2000). Oncogene, 19, 5435–5443.
Lallemand D, Ham J, Garbay S, Bakiri L, Traincard F, Jeannequin O, Pfarr CM and Yaniv M . (1998). EMBO J., 17, 5615–5626.
Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DR, Dean M, Glavac D, Richards F, Crossey PA, Ferguson-Smith MA, Paslier DL, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B and Lerman MI . (1993). Science, 260, 1317–1320.
Lee S, Chen DYT, Humphrey JS, Gnarra JR, Linehan WM and Klausner RD . (1996). Proc. Natl. Acad. Sci. USA, 93, 1770–1775.
Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky IA, Linehan WM, Vortmeyer AO and Zhuang Z . (1998a). Cancer Res., 58, 504–508.
Lee YS, Yuspa SH and Dlugosz AA . (1998b). J. Invest. Dermatol., 111, 762–766.
Lindon C, Albagli O, Pinset C and Montarras D . (2001). Dev. Biol., 240, 574–584.
Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW and Kaelin Jr WG . (1998). Mol. Cell. Biol., 18, 732–741.
Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM and Zhuang Z . (1996). Am. J. Pathol., 149, 2089–2094.
Mukhopadhyay D, Tsiokas L and Sukhatme VP . (1998). Gene Expr., 7, 53–60.
Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V and Kaelin WG . (2000). Nat. Cell. Biol., 2, 423–427.
Ostman A, Yang Q and Tonks NK . (1994). Proc. Natl. Acad. Sci. USA, 91, 9680–9684.
Pause A, Lee S, Lonergan KM and Klausner RD . (1998). Proc. Natl. Acad. Sci. USA, 95, 993–998.
Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM and Klausner RD . (1997). Proc. Natl. Acad. Sci. USA, 94, 2156–2161.
Schoenfeld A, Davidowitz EJ and Burk RD . (1998). Proc. Natl. Acad. Sci. USA, 95, 8817–8822.
Schoenfeld AR, Davidowitz EJ and Burk RD . (2000). Proc. Natl. Acad. Sci. USA, 97, 8507–8512.
Schoenfeld AR, Davidowitz EJ and Burk RD . (2001). Int. J. Cancer, 91, 457–467.
Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM and Clurman BE . (2000). Mol. Cell, 5, 403–410.
Singh RK, Llansa N, Bucana CD, Sanchez R, Koura A and Fidler IJ . (1996). Cell Growth Differ., 7, 397–404.
Stebbins CE, Kaelin WG and Pavletich NP . (1999). Science, 284, 451–461.
Tanimoto K, Makino Y, Pereira T and Poellinger L . (2000). EMBO J., 19, 4298–4309.
Acknowledgements
We thank Ana Maria Cuervo and Alan Schoenfeld for critical review of this manuscript. This work was supported by a grant from the National Cancer Institute, NIH (RO1 CA85412).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohan, S., Burk, R. von Hippel–Lindau protein complex is regulated by cell density. Oncogene 22, 5270–5280 (2003). https://doi.org/10.1038/sj.onc.1206592
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206592
